Press release
Chronic Kidney Disease Market Size, Share, Trends, History, Gross Margin and Forecasts To 2017
This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Chronic Kidney Disease market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Chronic Kidney Disease market growth. It takes into account aspects such as drivers, restraints, challenges, and opportunities that impact the market and presents statistical and analytical account on it. This research report features a comprehensive discussion about the current scenario to estimate trends and prospects of the Chronic Kidney Disease market soon. The overall market provides detailed dynamic and statistical insights pertaining to the market at both regional and global level.
Get Free Sample Copy of this Report @: http://www.reportbazzar.com/request-sample/?pid=988896&ptitle=Chronic+Kidney+Disease+%26%238211%3B+Pipeline+Review%2C+H1+2017&req=Sample
Healthcare industry: Is it growing or stagnant?
The healthcare industry or health economy is the aggregation or integration of industries within the economic system that provides goods & services to treat the patients with preventive, curative, palliative and rehabilitative care. Healthcare industry has been grabbing attention in the recent past and is expected to continue a similar trend over the forecast period. Growing number of diseases and increasing concern & awareness about health are the factors contributing to the growth of Chronic Kidney Disease industry and in turn healthcare industry and its related industries. Development of newer products coupled with innovation of new technologies, as well as increasing investments in R&D by companies, is further widening the market scope and revenue growth of the total market.
Research Methodology:
Recognizing the rising prevalence of Chronic Kidney Disease market, this research report proves to be a primary source of guidance and detailed data on the market at global scale. The report evaluates the present scenario as well as changing trends in the market to project its outlook and prospects. A holistic report covers exhaustive information obtained from reliable industrial sources and through proven research methodologies. The report goes through both secondary and primary survey. The base year taken for the report is 2015 and 2016, and a forecast is done from 2017 to 2025.The data thus obtained is then combined with relevant tables and graphs to support the information revealed.
Browse full report with Table of Content @: http://www.reportbazzar.com/product/chronic-kidney-disease-pipeline-review-h1-2017/
Product & Application Insights:
Various competent analytical tools have been used to offer a comprehensive assessment of the market. The report comprises of each aspect of the global market for Chronic Kidney Disease. It starts with the basic information and then advances to the market segmentation based on different criteria such as technology, products, application and regions in general. A detailed analysis is also given on the market penetration and future prospects of the overall industry growth. Each product has its specific applications. There is detailed approach provided for each product and application such has which product has the highest penetration and which application is growing at a significant rate. These factors are complemented by diagrams such as bar graph or pie diagram.
Regional Insights:
Major regions, countries, and sub-segments have been analyzed for providing the better understanding of the market scope worldwide. The regions taken into consideration are North America, Europe, Asia Pacific, Middle East & Africa and Central & South America. The report studies the market by evaluating the manufacturers, suppliers, and supply chain or value chain management. Favorable regulations, prevalent policies and cost structures are also analyzed. The regional markets for the Chronic Kidney Disease market are analyzed by evaluating the pricing of products, logistics, demand, and supply, production capacity, as well as the historical performance of the market in the given region.
Competitive Insights:
The report also provides insights on the competitive landscape of the global Chronic Kidney Disease industry with the leading players profiled in the report. Company profiles are purely tentative in nature and we can profile companies according to your interest at free cost. The Chronic Kidney Disease market is highly competitive and regulated. The company overview, trends, tactics, merger & acquisitions, business strategies, financial metrics of the major participants operating in the global Chronic Kidney Disease market have been reviewed in this study.
Ask for Discount @: http://www.reportbazzar.com/discount-form/?pid=988896&ptitle=Chronic+Kidney+Disease+%26%238211%3B+Pipeline+Review%2C+H1+2017&req=Discount
Some Points Of Table Of Content:
2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Chronic Kidney Disease (Chronic Renal Failure) - Overview 8
Chronic Kidney Disease (Chronic Renal Failure) - Therapeutics Development 9
Pipeline Overview 9
Pipeline by Companies 10
Pipeline by Universities/Institutes 14
Products under Development by Companies 15
Products under Development by Universities/Institutes 18
Chronic Kidney Disease (Chronic Renal Failure) - Therapeutics Assessment 19
Assessment by Target 19
Assessment by Mechanism of Action 22
Assessment by Route of Administration 25
Assessment by Molecule Type 27
Chronic Kidney Disease (Chronic Renal Failure) - Companies Involved in Therapeutics Development 29
Angion Biomedica Corp 29
apceth Biopharma GmbH 29
Astellas Pharma Inc 30
AstraZeneca Plc 30
Bayer AG 31
BLR Bio LLC 31
Boehringer Ingelheim GmbH 32
Boryung Pharmaceutical Co Ltd 32
Cellmid Ltd 33
Chugai Pharmaceutical Co Ltd 33
Complexa Inc 34
Corvidia Corp 34
CTI BioPharma Corp 35
Evotec AG 35
F. Hoffmann-La Roche Ltd 36
Gilead Sciences Inc 36
GNI Group Ltd 37
Lupin Ltd 37
Navya Biologicals Pvt Ltd 38
Nippon Zoki Pharmaceutical Co Ltd 38
Novartis AG 39
Otsuka Holdings Co Ltd 39
Prismic Pharmaceuticals Inc 40
Prolong Pharmaceuticals LLC 40
ProMetic Life Sciences Inc 41
Reata Pharmaceuticals Inc 41
Regulus Therapeutics Inc 42
Relypsa Inc 42
Resverlogix Corp 43
Spotlight Innovation Inc 43
Taisho Pharmaceutical Co Ltd 44
Toray Industries Inc 44
Tricida Inc 45
Unity Biotechnology Inc 45
Vascular BioSciences 46
VESSL Therapeutics Ltd 46
Vicore Pharma AB 47
Chronic Kidney Disease (Chronic Renal Failure) - Drug Profiles 48
(palmidrol + silibinin) - Drug Profile 48
ambrisentan - Drug Profile 49
ANG-3070 - Drug Profile 52
ANG-3281 - Drug Profile 53
ANG-3586 - Drug Profile 54
Antisense RNAi Oligonucleotides for Acute Kidney Injury and Chronic Kidney Disease - Drug Profile 55
apabetalone - Drug Profile 56
AS-2444697 - Drug Profile 68
bardoxolone methyl - Drug Profile 69
BI-655088 - Drug Profile 75
BKE-001 - Drug Profile 76
BLR-400 - Drug Profile 77
C-21 - Drug Profile 78
CAB-101 - Drug Profile 81
calcium succinate - Drug Profile 83
CAR Peptide - Drug Profile 84
cardiotoxin - Drug Profile 85
Cell Therapy for Chronic Kidney Disease and Metabolic Disorders - Drug Profile 86
COR-001 - Drug Profile 87
CXA-10 - Drug Profile 88
dapagliflozin propanediol - Drug Profile 89
Drug for Kidney Diseases - Drug Profile 96
Drug to Activate sGC for Chronic Kidney Disease - Drug Profile 97
EOS-789 - Drug Profile 98
F-351 - Drug Profile 99
finerenone - Drug Profile 101
FM-1302 - Drug Profile 103
KBP-5074 - Drug Profile 104
LHW-090 - Drug Profile 106
MultiGeneGraft - Drug Profile 107
NAV-003 - Drug Profile 108
NZ-419 - Drug Profile 109
obinutuzumab - Drug Profile 110
pacritinib - Drug Profile 118
patiromer sorbitex calcium - Drug Profile 131
PBI-4050 - Drug Profile 135
Recombinant Plasma Gelsolin Replacement for Renal Disease - Drug Profile 142
Recombinant Protein to Agonize ALK and BMP Receptors for Alport Syndrome, Kidney Diseases, Metabolic Disorders and Osteoarthritis - Drug Profile 143
Sanguinate - Drug Profile 145
Small Molecule to Agonize CaSR for Chronic Kidney Disease and Primary Hyperparathyroidism - Drug Profile 148
Small Molecule to Inhibit Sodium-Phosphate Cotransporter 2b for Chronic Kidney Disease - Drug Profile 149
Small Molecule to Inhibit Soluble Epoxide Hydrolase for Chronic Kidney Disease - Drug Profile 150
Small Molecules for Chronic Kidney Disease - Drug Profile 151
Small Molecules for Chronic Kidney Disease - Drug Profile 152
SP-20103 - Drug Profile 153
SPR-494 - Drug Profile 154
Stem Cell Therapy for Chronic Kidney Disease - Drug Profile 155
Stem Cell Therapy for Genito Urinary System And Sex Hormone Diseases, Immunology, Metabolic Disorders, Oncology and Respiratory Disease - Drug Profile 156
Synthetic Peptide to Modulate GHSR for Chronic Kidney Disease - Drug Profile 157
tesidolumab - Drug Profile 158
tolvaptan - Drug Profile 160
torsemide ER - Drug Profile 164
TRC-101 - Drug Profile 165
TS-143 - Drug Profile 166
verinurad - Drug Profile 167
Vida-5 - Drug Profile 169
VS-105 - Drug Profile 170
Wnt-001 - Drug Profile 171
YS-1402 - Drug Profile 172
Chronic Kidney Disease (Chronic Renal Failure) - Dormant Projects 173
Chronic Kidney Disease (Chronic Renal Failure) - Discontinued Products 175
Chronic Kidney Disease (Chronic Renal Failure) - Product Development Milestones 176
Featured News & Press Releases 176
Appendix 190
Methodology 190
Coverage 190
Secondary Research 190
Primary Research 190
Expert Panel Validation 190
Contact Us 190
Disclaimer 191
About us:
Reportbazzar.com is your trusted source for the most inclusive and informative assortment of market research reports designed to empower you with the latest in industry information that translates to time and cost savings for your business. We not only help you give wing to your latent business ideas but also facilitate you in taking the best informed and strategic decisions that guarantee success in your most promising business endeavors. Our intelligence database comprises of vast arrays of strategically analyzed and high-level market research reports that encompass all major industries worldwide. All the specialized research reports available at Reportbazzar.com are tailor-made to suit your every business need, no matter how diverse or demanding it is.
Contact for more details:
Report Bazzar
United States
30 Wall Street, 8th floor,
New York, NY 10005.
US: +1 (212) 389-6363
Email: sales@reportbazzar.com
Web -http://www.reportbazzar.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Kidney Disease Market Size, Share, Trends, History, Gross Margin and Forecasts To 2017 here
News-ID: 586623 • Views: …
More Releases from ReportBazzar
Global Plasma Protein Therapeutic Industry Market Analysis & Forecast 2018-2023
Global Plasma Protein Therapeutic Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX%…
Developments and Opportunities for Facial Recognition Technology in the Smart Re …
Facial recognition technology has been commercialized since the late 1990s. However, it did not quite get the attention it deserved until the September 11 attacks. Since then, market demand for advanced human-machine interaction interfaces soared in national security and personal property security in light of the rising awareness on anti-terrorism, the change in economic activities from traditional offline transactions to e-commerce and the lifestyle evolution which now craves for smart…
Floating Solar Panels Market Research Report – Forecast to 2023
Global floating solar panels market is set to foresee significant growth in the upcoming years. Floating solar panels is a sophisticated technology developed for overcoming issues associated with conventional panels, such as high maintenance cost, land scarcity, etc. These panels are poised to gain traction over the next couple of years owing to its mobility and flexibility according to the sun’s position.
The rapid exhaustion of fossil fuel has intensified the…
Healthcare cold chain logistics Market Research Report – Forecast to 2023
The healthcare cold chain logistics market is one with a lot of promise largely due to the rapid growth of the healthcare and pharmaceutical sectors. With healthcare becoming a global focus, and intensive research & development activities being carried out by leading market players has significantly increased the demand for biopharmaceuticals and vaccines. These products traditionally, and presently require storage to ensure appropriate shelf life.
Personalized medicine is an up…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
